Hackett v. Skynet Industries, Inc.

No. 25-cv-03297-RFL (N.D. Cal. Oct. 24, 2025) · United States District Court for the Northern District of California · October 24, 2025 · No. 3:25-cv-03297

Summary

The United States District Court for the Northern District of California partially granted and partially denied Skynet Industries, Inc.’s motion to dismiss a putative nationwide class action concerning alleged omissions about the addictive nature and safety risks of kratom products. The court dismissed the implied warranty and California Consumer Legal Remedies Act section 1770(a)(9) claims with prejudice, while allowing the remaining claims and class allegations to proceed. The court also held that CAFA jurisdiction, reliance, a duty to disclose, and timeliness were adequately alleged at the pleading stage.

Holdings

  1. The court has subject matter jurisdiction under the Class Action Fairness Act because the citizenship and amount in controversy requirements are met.
  2. The claims are not barred as a matter of law by the statutes of limitations because the discovery rule applies to fraud claims and Hackett adequately alleges accrual in November 2024.
  3. Hackett sufficiently alleges reliance by stating he would have behaved differently had the omitted information been disclosed.
  4. Hackett adequately pleads that Skynet had a duty to disclose because the products' addictiveness constitutes an unreasonable safety hazard.
  5. The unjust enrichment claim survives because it is construed as a quasi-contract claim seeking restitution, and Hackett sufficiently alleges an unjustly retained benefit.
  6. Hackett's claims satisfy Rule 9(b)'s heightened pleading requirements; none of the purported deficiencies identified by Skynet require dismissal.

Questions Presented

  1. Whether the court has subject matter jurisdiction under the Class Action Fairness Act
  2. Whether Hackett's claims are barred by the applicable statutes of limitations
  3. Whether Hackett sufficiently alleges reliance on Skynet's omissions
  4. Whether Skynet had a duty to disclose kratom's addictive properties
  5. Whether Hackett's unjust enrichment claim is viable
  6. Whether Hackett's claims satisfy Rule 9(b) heightened pleading requirements

Disposition

affirmed_in_part_and_reversed_in_part

Cases Cited (15)

  • Washington v. Chimei Innolux Corp., 659 F.3d 842 (9th Cir. 2011)(cited)
  • Rosenwald v. Kimberly-Clark Corp., 152 F.4th 1167 (9th Cir. 2025)(cited)
  • Robichaud v. Speedy PC Software, No. 12-cv-04730-LB, 2013 WL 818503 (N.D. Cal. Mar. 5, 2013)(cited)
  • De Ciel v. Porter, No. 25-cv-03351-JSC, 2025 WL 2483160 (N.D. Cal. Aug. 28, 2025)(cited)
  • Fox v. Ethicon Endo-Surgery, Inc., 35 Cal. 4th 797 (2005)(cited)
  • Jolly v. Eli Lilly & Co., 44 Cal. 3d 1103 (1988)(cited)
  • E-Fab, Inc. v. Accts., Inc. Servs., 153 Cal. App. 4th 1308 (6th Dist. 2007)(cited)
  • Daniel v. Ford Motor Co., 806 F.3d 1217 (9th Cir. 2015)(cited)
  • Hodsdon v. Mars, Inc., 891 F.3d 857 (9th Cir. 2018)(cited)
  • Hammerling v. Google LLC, 615 F. Supp. 3d 1069 (N.D. Cal. 2022)(cited)

Showing top 10 of 15.

Cited In (0)

No citing cases on record yet.

Court Document

Open PDF
Loading document…